Skip to main content
Market intelligence
ARQTHealthcare

Arcutis Biotherapeutics Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 3, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 3, 2026Patrick BurnettSee RemarksSale955$26.12$24,942
Aug 3, 2026Masaru MatsudaSee RemarksSale1,230$26.12$32,124
Aug 3, 2026Todd WatanabeSee RemarksSale4,375$26.12$114,261